Home Tags Allergan

Tag: Allergan

In July, Allergan voluntarily recalled the cancer-linked implants at the request of the FDA.

Women share what it’s like to have ‘ticking time bomb’ breast implants that have been linked to cancer

The Allergan breast implant recall has affected women's lives physically, emotionally, and financially as they grapple with an increased cancer risk.
Robbie Hegwood with her family.

A woman got breast implants after a breast cancer diagnosis. Then she got cancer linked to the implants.

Robbie Hegwood's breast implants led her to develop a rare cancer called BIA-ALCL. She got the implants after breast cancer.
In a new letter to healthcare providers, the FDA said it wants to raise awareness of a rare cancer that's associated with breast implants.

A lawsuit claims a major breast implant maker knew its implants were likely causing cancer, and hid the complaints using fake company names

Allergan reportedly used names like "Costa Rica" and "Santa Barbra" to file reports about their Biocell implants, which have been linked to cancer.

Two women have filed a class-action lawsuit against a major breast implant maker after hundreds of Americans developed a rare cancer linked to implant...

The women who sued Allergan said they wouldn't have gotten the Biocell implants if they about knew the cancer-related risks.

Dispensed: Pharma’s next big megamerger, a string of healthcare IPOs, and why the CEO of Clover Health regrets setting up shop in Silicon Valley...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Botox is made from the deadliest toxin on earth. Then we started injecting it in our faces.

Here's the history of how Botox went from an understudied toxin to a blockbuster drug used by millions.
Allergan CEO Brent Saunders

Allergan started out as a tiny but beloved Southern California eye care firm before expanding to a $130 billion company. Here’s how the Botox-ma...

Here's how Allergan went from its start as a sleepy but beloved company out of Southern California in the 1950s to an acquisition target for AbbVie.

Allergan spikes 30% after AbbVie agrees to buy the Botox-maker for $63 billion

AbbVie expects the acquisition to generate at least $2 billion in pre-tax synergies and cost reductions within three years.

Abbvie is buying Allergan in a $63 billion pharma mega-deal

The biopharmaceuticals giant and drugmaker want to create a leader across immunology, neuroscience, eye care, and other medical fields.

A fresh crop of promising drugs is poised to change the way depression is treated for the first time in decades. Here are the ones to watch in 2019.

Researchers are on the hunt for better drugs to treat depression, a leading cause of disability worldwide. Promising options include ketamine and psilocybin.